Company Arsanis Inc Nasdaq
Equities
US0428731097
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 09-12-31 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 23-07-31 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 20-11-01 |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | - | 22-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 18-06-30 |
David McGirr
BRD | Director/Board Member | 69 | 17-08-31 |
Paula Ragan
FOU | Founder | 54 | 09-12-31 |
Gary Bridger
BRD | Director/Board Member | 61 | 18-09-30 |
Alison Lawton
BRD | Director/Board Member | 62 | 20-10-04 |
Bill Aliski
BRD | Director/Board Member | 75 | 19-09-17 |
Director/Board Member | 62 | 21-10-13 | |
Murray Stewart
BRD | Director/Board Member | 63 | 19-03-28 |
R. Woods
BRD | Director/Board Member | 57 | 23-10-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,937,781 | 162,995,043 ( 97.06 %) | 0 | 97.06 % |
Company contact information
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |